NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 179 filers reported holding NOVAVAX INC in Q4 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $297,000 | -54.4% | 35,380 | -61.6% | 0.02% | -58.5% |
| Q3 2015 | $651,000 | +6.2% | 92,108 | +67.5% | 0.04% | +24.2% |
| Q2 2015 | $613,000 | +233.2% | 55,002 | +147.7% | 0.03% | +230.0% |
| Q1 2015 | $184,000 | -2.1% | 22,209 | -30.0% | 0.01% | 0.0% |
| Q4 2014 | $188,000 | -6.5% | 31,717 | -34.2% | 0.01% | -9.1% |
| Q3 2014 | $201,000 | -9.9% | 48,206 | 0.0% | 0.01% | -8.3% |
| Q2 2014 | $223,000 | +2.3% | 48,206 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $218,000 | – | 48,206 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |